p53 mutations in non-small-cell lung cancers occurring in individuals without a past history of active smoking

British Journal of Cancer

Volumn 77, Issue 10, 1998, Pages 1568-1572

  Takagi, Y ^a,b   Osada, H ^a   Kuroishi, T ^a   Mitsudomi, T ^a   Kondo, M ^a   Niimi, T ^c   Saji, S ^b   Gazdar, A F ^d   Takahashi, T ^a,a   Minna, J D ^d  

^a AICHI CANCER CENTER HOSPITAL   (Japan)

^b GIFU UNIVERSITY   (Japan)

^c CHUBU NATIONAL HOSPITAL   (Japan)

^d UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Lung cancer; Mutation; p53; Smoking

Indexed keywords

MUTANT PROTEIN; PROTEIN P53;

ADULT; AGED; ARTICLE; FEMALE; HUMAN; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; NUCLEIC ACID BASE SUBSTITUTION; PRIORITY JOURNAL; SMOKING;

EID: 7144261700     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1998.258     Document Type: Article

References (40)

1. Chiba I, Takahashi T, Nau M, D'Amico D, Curiel D, Mitsudomi T, DL B, Carbone D, Piantadosi S, Koga H, Reissmann P, Slamon D, Holmes E and Minna J (1990) Mutations in the p53 gene are frequent in primary, resected non-small cell lung cancer. Oncogene 5: 1603-1610
2. D'Amico D, Carbone D, Mitsudomi T, Nan M, Fedorko J, Russell E, Johnson B, Buchhagen D, Bodner S, Phelps R, Gazdar A and Minna J (1992) High frequency of somatically acquired p53 mutations in small-cell lung cancer cell lines and tumours. Oncogene 7: 339-346
3. Doll R and Hill AB (1950) Smoking and carcinoma of the lung. Br Med J 2: 739-748
4. Fridovich I (1983) Superoxide radical: an endogenous toxicant. Annu Rev Pharmacol Toxicol 23: 239-257
5. Greenblatt MS, Bennett WP, Hollstein M and Harris CC (1994) Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res 54: 4855-4878
6. Hainaul P, Soussi T, Shomer B, Hollstein M, Greenblatt M. Hovig E, Harris CC and Montesano R (1997) Database of p53 gene somatic mutations in human tumors and cell lines: updated compilation and future prospects. Nucleic Acid Res 25: 141-146
7. Hanui A, Benn T, Fujimoto S and Muir CS (1988) Comparison of lung cancer incidence rales by histological type in high and low incidence countries, with reference to the limited role of smoking. Jpn J Cancer Res 79: 445-452
8. Harbour J W, Lai SL, Whang-Peng J, Gazdar AF, Minna JD and Kaye FJ (1988) Abnormalities in structure and expression of the human retinoblastoma gene in SCLC, Science 241: 353-357
9. Hibi K, Takahashi T, Yamakawa K, Ueda R, Sekido Y, Ariyoshi Y, Suyama M, Takagi H, Nakamura Y and Takahashi T (1992) Three distinct regions involved in 3p deletion in human lung cancer. Oncogene 7: 445-449
10. Hollstein M, Sidransky D, Vogelstein B and Harris CC (1991) p53 mutations in human cancers. Science 253: 49-53
11. Horio Y, Takahashi T, Kuroishi T, Hibi K, Suyama M, Niimi T, Shimokata K, Yamakawa K, Nakamura Y, Ueda R and Takahashi T (1993) Prognostic significance of p53 mutations and 3p deletions in primary resected non-small cell cancer. Cancer Res 53: 1-4
12. Horio Y, Suzuki H, Ueda R, Koshikawa T, Sugiura T, Ariyoshi Y, Shimokata K, Takahashi T and Takahashi T (1994) Predominantly tumor-limited expression of a mutant allele in a Japanese family carrying a germline p53 mutation. Oncogene 9: 1231-1235
13. KIP2 gene at 11 p 15.5 Oncogene 12: 1365-1368
14. Levin ML, Goldstein H and Gerhardt PR (1950) Cancer and tobacco smoking. J Am Med Assoc 143: 336-338
15. McBride TJ (1992) Mutations induced by methylene blue plus light in single-stranded M13mp2. Proc Natl Acad Sci USA 89: 6866-6870
16. Matsukura S, Taminato T, Kitano N, Seino Y, Hamada H, Uchihashi M, Nakajima H and Hirata Y (1984) Effects of environmental tobacco smoke on urinary cotinine excretion in nonsmokers: evidence for passive smoking. N Engl J Med 311: 828-832
17. Miller CW, Simon K, Aslo A, Kok K, Yokota J, Buys CHCM, Terada M and Koeffler HP (1992) p53 mutations in human lung tumours. Cancer Res 52: 1695-1698
18. Mitsudomi T, Steinberg SM, Nau MM, Carbone D, D'Amico D, Bodner S, Oie HK, Linnoila RJ, Mulshine JL, Minna JD and Gazdar AF (1992) p53 gene mutations in non-small cell lung cancer cell lines and their correlation with the presence of ras mutations and clinical fealures. Oncogene 7: 171-180
19. Moriya M, Ou C, Bodepudi V, Johnson F, Takeshita M and Grollman AP (1991) Site-specific mutagenesis using a gapped duplex vector: a study of translesion synthesis past 8-oxodeoxyguanosine in E. coli. Mutat Res 254: 281-288
20. Muler FH (1939) Tobacco abuse and carcinoma of the lung. Z Krebsforschung 49: 57-85
21. Nagatake M, Osada H, Kondo M, Uehida K, Nishio M, Shimokata K, Takahashi T and Takahashi T (1996a) Aberrant hypermethylation at the bcl-2 locus at 18q21 in human lung cancers. Cancer Res 56: 1886-1891
22. Nagatake M, Takagi Y, Osada H, Uehida K, Mitsudomi T, Saji S, Shimokata K, Takahashi T and Takahashi T (1996b) Somatic in vivo alterations of the DPC4 gene at 18q21 in human lung cancers. Cancer Res 56: 2718-2720
23. Naylor SL, Johnson BE, Minna JD and Sakaguchi AY (1987) Loss of heterozygosity of chromosome 3p markers in small-cell lung cancer. Naturc 329: 451-454
24. Reid TM and Loeb LA (1993) Tandem double CC→TT mutations are produced by reactive oxygen species. Proc Natl Acad Sci USA 90: 3904-3907
25. Rodenhuis S, van de Wetering ML, Mooi WJ, Evers SG, van Zandwijk N and Bos JF (1987) Mutational activation of the K-ras oncogene: a possible pathogenetic factor in adenocarcinoma of the lung. N Eng J Med 317: 929-935
26. Shopland DR, Eyre HJ and Pechacek TF (1991) Smoking-altributable cancer mortality in 1991 : is lung cancer now the leading cause of death among smokers in the United States? J Natl Cancer Inst 83: 1142-1148
27. Suzuki H, Takahashi T, Kuroishi T, Suyama M, Ariyoshi Y, Takahashi T and Ueda R (1992) p53 mutations in non-small cell lung cancer in Japan: association between mutations and smoking, Cancer Res 52: 734-736
28. Suzuki H, Ueda R, Takahashi T and Takahashi T (1994) Altered imprinting in lung cancer. Nature Genet 6: 332-333
29. Takagi Y, Koo LC, Osada H, Ueda R, Kyaw K, Ma C, Suyama M, Saji S, Takahashi T. Tominaga S and Takahashi T (1995) Distinct mutational spectrum of the p53 gene in lung cancers from Chinese women in Hong Kong. Cancer Res 55: 5354-5357
30. Takahashi T, Nau MM, China I, Birrer MJ, Rosenberg RK, Vinocour M, Levitt M, Pass H, Gazdar AF and Minna JD (1989) p53: a frequent target for genetic abnormalities in lung cancer. Science 246: 491-494
31. Takahashi T, Takahashi T, Suzuki H, Hida T, Sekido Y, Ariyoshi Y and Ueda R (1991) The p53 gene is very frequently mutated in small-cell lung cancer with a distinct nucleotide substitution paltern. Oncogene 6: 1775-1778
32. Takahashi T, Carbone D, Takahashi T, Nau MM, Hida T, Ilona L, Ueda R and Minna JD (1942) Wild-type but not mutant p53 suppresses the growth of human lung cancer cells bearing multiple genetic lesions. Cancer Res 52: 2340-2343
33. Takeshima Y, Seyama T, Bennett WP, Akiyama M, Tokuoka S, Inai L, Mabuchi K, Land CE and Harris CC (1993) p53 mutations in lung cancers from non-smoking atomic-bomb survivors. Lancet 342: 1520-1521
34. Tkeshelashvili LK, Reid TM, McBride TJ and Loeh LA (1993) Nickel induces a signature mutation for oxygen free radical damage. Cancer Res 53: 4172-4174
35. Travis WD, Travis LB and Devesa SS (1994) Lung cancer. Cancer 75: 191-202
36. US Department of Health and Human Services (1989) Reducing the Health Consequences of Smoking, 25 Years report of the surgcon general. U.S. Department of Health and Human Services, DHHS Publication No. (CDC) 89-8411
37. US Public Health Service (1964) Smoking and Health. Report of the advisory commitlee to the surgeon general of the public health service. US Department of Health. Education, and Welfare, PHS Publication No. 1103
38. Washimi O, Nagatake M, Osada H, Ueda R, Koshikawa T, Seki T, Takahashi T and Takahashi T (1995) In vivo occurrence of p16 (MTS1) and p15 (MTS2) alterations preferentially in non-small cell lung cancers. Cancer Res 55: 514-517
39. Watanabe S, Tsugane S, Arimoto H, Shimosato Y, Suemasu K, Arai H and Urano Y (1987) Trend of lung cancers in the National Cancer Center of Japan and comparison with that of Japanese pathological autopsy records. Jpn J Cancer Res 78: 460-466
40. Wynder EL and Graham EA (1950) Tobacco smoking as a possible etiologic factor in bronchiogenic carcinoma. J Am Med Assoc 143: 329-336